S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
Log in
NASDAQ:OHRP

OHR Pharmaceutical Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$9.27
-0.66 (-6.65 %)
(As of 03/2/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.23
Now: $9.27
$9.93
50-Day Range
$5.39
MA: $7.37
$9.07
52-Week Range
$1.60
Now: $9.27
$6.28
Volume110,723 shs
Average Volume180,228 shs
Market Capitalization$26.22 million
P/E RatioN/A
Dividend YieldN/A
Beta0.84
OHR Pharmaceutical, Inc. operates as a development stage pharmaceutical company. The company intends to merge with NeuBase Therapeutics, Inc. that focuses on advancing NeuBase's peptide-nucleic acid antisense oligonucleotide technology platform for the development of therapies to address severe and currently untreatable diseases caused by genetic mutations. OHR Pharmaceutical, Inc. is headquartered in New York, New York.
OHR Pharmaceutical logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:OHRP
CUSIPN/A
Phone212-682-8452
Employees3
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$3.86 per share

Profitability

Net Income$-13,230,000.00

Miscellaneous

Market Cap$26.22 million
Next Earnings DateN/A
OptionableOptionable

MarketRank

Overall MarketRank

0.56 out of 5 stars

Medical Sector

1396th out of 1,969 stocks

Pharmaceutical Preparations Industry

614th out of 772 stocks

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Receive OHRP News and Ratings via Email

Sign-up to receive the latest news and ratings for OHRP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











OHR Pharmaceutical (NASDAQ:OHRP) Frequently Asked Questions

What stocks does MarketBeat like better than OHR Pharmaceutical?

Wall Street analysts have given OHR Pharmaceutical a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but OHR Pharmaceutical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were OHR Pharmaceutical's earnings last quarter?

OHR Pharmaceutical Inc (NASDAQ:OHRP) posted its earnings results on Tuesday, August, 14th. The biotechnology company reported ($0.20) earnings per share (EPS) for the quarter.
View OHR Pharmaceutical's earnings history
.

When did OHR Pharmaceutical's stock split? How did OHR Pharmaceutical's stock split work?

OHR Pharmaceutical's stock reverse split before market open on Monday, February 4th 2019. The 1-20 reverse split was announced on Wednesday, January 23rd 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 1st 2019. An investor that had 100 shares of OHR Pharmaceutical stock prior to the reverse split would have 5 shares after the split.

Who are OHR Pharmaceutical's key executives?

OHR Pharmaceutical's management team includes the following people:
  • Dr. Jason Scott Slakter, CEO, Pres & Director (Age 61)
  • Mr. Samuel Backenroth, CFO, VP of Bus. Devel. & Sec. (Age 35)
  • Dr. Glenn L. Stoller M.D., Chief Scientific Officer (Age 55)
  • Dr. Marlene Modi, Head of Preclinical & Regulatory Affairs

Who are some of OHR Pharmaceutical's key competitors?

What other stocks do shareholders of OHR Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OHR Pharmaceutical investors own include Actinium Pharmaceuticals (ATNM), TherapeuticsMD (TXMD), Cytori Therapeutics (CYTX), Synergy Pharmaceuticals (SGYP), IVERIC bio (OPHT), Novavax (NVAX), Immunomedics (IMMU), OPKO Health (OPK), Dynavax Technologies (DVAX) and Energy Transfer (ET).

What is OHR Pharmaceutical's stock symbol?

OHR Pharmaceutical trades on the NASDAQ under the ticker symbol "OHRP."

What is OHR Pharmaceutical's stock price today?

One share of OHRP stock can currently be purchased for approximately $9.27.

How much money does OHR Pharmaceutical make?

OHR Pharmaceutical has a market capitalization of $26.22 million.

How many employees does OHR Pharmaceutical have?

OHR Pharmaceutical employs 3 workers across the globe.

What is OHR Pharmaceutical's official website?

The official website for OHR Pharmaceutical is www.ohrpharmaceutical.com.

Where are OHR Pharmaceutical's headquarters?

OHR Pharmaceutical is headquartered at 800 THIRD AVENUE 11TH FLOOR, NEW YORK NY, 10022.

How can I contact OHR Pharmaceutical?

OHR Pharmaceutical's mailing address is 800 THIRD AVENUE 11TH FLOOR, NEW YORK NY, 10022. The biotechnology company can be reached via phone at 212-682-8452 or via email at [email protected]


This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.